Literature DB >> 32264626

Stimuli-responsive delivery vehicles based on mesoporous silica nanoparticles: recent advances and challenges.

Jianhua Zhu1, Yimin Niu, Yang Li, Yaxiang Gong, Huihui Shi, Qiang Huo, Yang Liu, Qunwei Xu.   

Abstract

In the past decade, stimuli-responsive drug delivery vehicles based on surface-functionalized mesoporous silica nanoparticles (MSNs) have attracted intense interest as a new type of drug carrier. These intelligent drug delivery systems have been demonstrated to enable precise drug release into highly specified targets and exhibit nearly "zero premature release" in systemic circulation. It is expected that an in-depth understanding of the basic mechanisms of the MSN-based stimuli-responsive drug delivery systems (DDSs) would further contribute to this breakthrough field of nanomedicine. In this review, the recent advances in the development of stimuli-responsive systems based on MSNs are summarized and discussed, including single stimuli-responsive DDSs, dual stimuli-responsive DDSs and multi stimuli-responsive DDSs. The challenges for stimuli-responsive DDSs based on MSNs with regards to future translation into clinical use are also simply discussed.

Entities:  

Year:  2017        PMID: 32264626     DOI: 10.1039/c6tb03066a

Source DB:  PubMed          Journal:  J Mater Chem B        ISSN: 2050-750X            Impact factor:   6.331


  11 in total

1.  Amphiphilic hyperbranched polyester coated rod mesoporous silica nanoparticles for pH-responsive doxorubicin delivery.

Authors:  Reza Bafkary; Shirin Ahmadi; Faeze Fayazi; Mehdi Karimi; Yousef Fatahi; Seyed Mostafa Ebrahimi; Fatemeh Atyabi; Rassoul Dinarvand
Journal:  Daru       Date:  2020-01-31       Impact factor: 3.117

2.  Modification of glass-ionomer cement properties by quaternized chitosan-coated nanoparticles.

Authors:  Enas A Elshenawy; Manal Ahmed El-Ebiary; El-Refaie Kenawy; Gehan Abdelmonem El-Olimy
Journal:  Odontology       Date:  2022-09-07       Impact factor: 2.885

3.  Multiple-responsive supramolecular vesicle based on azobenzene-cyclodextrin host-guest interaction.

Authors:  Jiao Wang; Ting Wang; Xiaohui Liu; Yan Lu; Jingjing Geng
Journal:  RSC Adv       Date:  2020-05-14       Impact factor: 4.036

Review 4.  Nanoarchitectured prototypes of mesoporous silica nanoparticles for innovative biomedical applications.

Authors:  Ranjith Kumar Kankala; Ya-Hui Han; Hong-Ying Xia; Shi-Bin Wang; Ai-Zheng Chen
Journal:  J Nanobiotechnology       Date:  2022-03-12       Impact factor: 10.435

Review 5.  Mesoporous Silica Platforms with Potential Applications in Release and Adsorption of Active Agents.

Authors:  Cristina Chircov; Angela Spoială; Cătălin Păun; Luminița Crăciun; Denisa Ficai; Anton Ficai; Ecaterina Andronescu; Ștefan Claudiu Turculeƫ
Journal:  Molecules       Date:  2020-08-21       Impact factor: 4.411

Review 6.  Current Stimuli-Responsive Mesoporous Silica Nanoparticles for Cancer Therapy.

Authors:  Thashini Moodley; Moganavelli Singh
Journal:  Pharmaceutics       Date:  2021-01-07       Impact factor: 6.321

7.  Nanoantioxidant-Based Silica Particles as Flavonoid Carrier for Drug Delivery Applications.

Authors:  Francisco Arriagada; Germán Günther; Javier Morales
Journal:  Pharmaceutics       Date:  2020-03-26       Impact factor: 6.321

8.  A pH/ROS cascade-responsive and self-accelerating drug release nanosystem for the targeted treatment of multi-drug-resistant colon cancer.

Authors:  Na Chang; Yufei Zhao; Ning Ge; Liting Qian
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.819

9.  Targeted and redox-responsive drug delivery systems based on carbonic anhydrase IX-decorated mesoporous silica nanoparticles for cancer therapy.

Authors:  Minmin Chen; Jinxia Hu; Lujing Wang; Yanru Li; Chenghao Zhu; Chen Chen; Ming Shi; Zhicheng Ju; Xichuan Cao; Zhuoqi Zhang
Journal:  Sci Rep       Date:  2020-09-02       Impact factor: 4.379

10.  The Role of Transmission Electron Microscopy in the Early Development of Mesoporous Materials for Tissue Regeneration and Drug Delivery Applications.

Authors:  María Luisa Ruiz-González; Almudena Torres-Pardo; José M González-Calbet
Journal:  Pharmaceutics       Date:  2021-12-20       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.